Covered recipient · General Payments record
LESLIE ERIN GILBERT
Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology
General Payments · PY2018–2024
$8,076.68
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $407.63 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $174.23 | 4 |
| CSL Behring | $125.03 | 2 |
| Genentech, Inc. | $37.15 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $33.92 | 1 |
| Kedrion Biopharma, Inc. | $23.60 | 1 |
| Novo Nordisk AS | $13.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| CSL Behring | $100.14 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134635781 | CMS |
| CSL Behring | $24.89 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134635773 | CMS |
| Genentech, Inc. | $18.89 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133053732 | CMS |
| Genentech, Inc. | $18.26 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133053737 | CMS |
| GENZYME CORPORATION | $23.32 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139899374 | CMS |
| GENZYME CORPORATION | $91.92 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139899392 | CMS |
| GENZYME CORPORATION | $31.64 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139899410 | CMS |
| GENZYME CORPORATION | $27.35 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139899428 | CMS |
| Kedrion Biopharma, Inc. | $23.60 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125862020 | CMS |
| Novartis Pharmaceuticals Corporation | $33.92 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086796395 | CMS |
| Novo Nordisk Inc | $13.70 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097273506 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.